Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for smoking cessation after invasive coronary artery disease treatment
IRCT20200719048133N1Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of varenicline in nicotine dependence and coronary arteriosclerosis, sponsored by Tehran University of Medical Sciences. Started Aug 2020; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependencecoronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20200719048133N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200719048133N1.